Riverbridge Partners LLC Johnson & Johnson Transaction History

Riverbridge Partners LLC

$7.23 Billion
Q3 2024

A detailed history of Riverbridge Partners LLC transactions in Johnson & Johnson stock. As of the latest transaction made, Riverbridge Partners LLC holds 11,542 shares of JNJ stock, worth $1.67 Million. This represents 0.03% of its overall portfolio holdings.

Number of Shares

11,542

Previous 11,972 3.59%

Holding current value

$1.67 Million

Previous $1.75 Million 6.92%

% of portfolio

0.03%

Previous 0.02%

31 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 15, 2024	SELL	$145.48 - $167.38 $62,556 - $71,973	-430 Reduced 3.59%	11,542 $1.87 Million
Q2 2024 Jul 17, 2024	SELL	$144.38 - $157.78 $19,202 - $20,984	-133 Reduced 1.1%	11,972 $1.75 Million
Q1 2024 Apr 26, 2024	SELL	$155.22 - $162.74 $403,261 - $422,798	-2,598 Reduced 17.67%	12,105 $1.91 Million
Q4 2023 Feb 15, 2024	SELL	$145.6 - $158.88 $114,150 - $124,561	-784 Reduced 5.06%	14,703 $2.3 Million
Q4 2023 Jan 24, 2024	SELL	$145.6 - $158.88 $114,150 - $124,561	-784 Reduced 5.06%	14,703 $2.3 Million
Q3 2023 Feb 15, 2024	BUY	$155.75 - $174.48 $122,108 - $136,792	784 Added 5.33%	15,487 $2.41 Million
Q3 2023 Oct 16, 2023	SELL	$155.75 - $174.48 $50,463 - $56,531	-324 Reduced 2.05%	15,487 $2.41 Million
Q2 2023 Jul 25, 2023	SELL	$154.35 - $166.11 $89,214 - $96,011	-578 Reduced 3.53%	15,811 $2.62 Million
Q1 2023 Apr 21, 2023	SELL	$151.05 - $180.26 $63,289 - $75,528	-419 Reduced 2.49%	16,389 $2.54 Million
Q4 2022 Jan 11, 2023	SELL	$160.2 - $179.79 $43,254 - $48,543	-270 Reduced 1.58%	16,808 $2.97 Million
Q3 2022 Oct 26, 2022	SELL	$161.33 - $179.52 $10,002 - $11,130	-62 Reduced 0.36%	17,078 $2.79 Million
Q2 2022 Jul 11, 2022	SELL	$168.19 - $186.01 $26,405 - $29,203	-157 Reduced 0.91%	17,140 $3.04 Million
Q1 2022 Apr 20, 2022	SELL	$158.14 - $179.59 $118,604 - $134,692	-750 Reduced 4.16%	17,297 $3.07 Million
Q4 2021 Jan 14, 2022	SELL	$155.93 - $173.01 $150,628 - $167,127	-966 Reduced 5.08%	18,047 $3.09 Million
Q3 2021 Oct 26, 2021	SELL	$161.5 - $179.47 $58,301 - $64,788	-361 Reduced 1.86%	19,013 $3.07 Million
Q2 2021 Jul 26, 2021	SELL	$159.48 - $171.07 $44,973 - $48,241	-282 Reduced 1.43%	19,374 $3.19 Million
Q1 2021 Apr 21, 2021	SELL	$153.07 - $170.48 $30,767 - $34,266	-201 Reduced 1.01%	19,656 $3.23 Million
Q4 2020 Jan 22, 2021	SELL	$137.11 - $157.38 $214,577 - $246,299	-1,565 Reduced 7.31%	19,857 $3.13 Million
Q3 2020 Oct 08, 2020	SELL	$140.38 - $153.83 $208,464 - $228,437	-1,485 Reduced 6.48%	21,422 $3.19 Million
Q2 2020 Jul 08, 2020	BUY	$128.81 - $155.51 $191,926 - $231,709	1,490 Added 6.96%	22,907 $3.22 Million
Q1 2020 Apr 13, 2020	SELL	$111.14 - $153.99 $249,620 - $345,861	-2,246 Reduced 9.49%	21,417 $2.81 Million
Q4 2019 Jan 14, 2020	SELL	$127.5 - $146.44 $32,895 - $37,781	-258 Reduced 1.08%	23,663 $3.45 Million
Q3 2019 Oct 11, 2019	SELL	$126.95 - $142.14 $24,120 - $27,006	-190 Reduced 0.79%	23,921 $3.1 Million
Q2 2019 Jul 10, 2019	SELL	$131.15 - $144.24 $51,541 - $56,686	-393 Reduced 1.6%	24,111 $3.36 Million
Q1 2019 Apr 04, 2019	SELL	$125.72 - $139.79 $24,641 - $27,398	-196 Reduced 0.79%	24,504 $3.43 Million
Q4 2018 Jan 14, 2019	SELL	$122.84 - $147.84 $132,298 - $159,223	-1,077 Reduced 4.18%	24,700 $3.19 Million
Q3 2018 Oct 03, 2018	SELL	$121.58 - $142.88 $36,838 - $43,292	-303 Reduced 1.16%	25,777 $3.56 Million
Q2 2018 Jul 03, 2018	SELL	$119.4 - $131.76 $264,948 - $292,375	-2,219 Reduced 7.84%	26,080 $3.17 Million
Q1 2018 Apr 03, 2018	SELL	$125.1 - $148.14 $163,630 - $193,767	-1,308 Reduced 4.42%	28,299 $3.63 Million
Q4 2017 Jan 24, 2018	BUY	$131.22 - $143.62 $162,581 - $177,945	1,239 Added 4.37%	29,607 $4.14 Million
Q3 2017 Nov 01, 2017	BUY	$129.47 - $135.38 $3.67 Million - $3.84 Million	28,368	28,368 $3.69 Million

Others Institutions Holding JNJ

# of Institutions

4,275

Shares Held

1.68B

Call Options Held

17.6M

Put Options Held

14.5M

View Full List

About JOHNSON & JOHNSON

Ticker JNJ
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,614,479,872
Market Cap $379B
Description
Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...

More about JNJ

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Riverbridge Partners LLC, based on Form 13F filings with the SEC.

News

Stay updated on Riverbridge Partners LLC with notifications on news.

Account

Riverbridge Partners LLC Johnson & Johnson Transaction History